✦ LIBER ✦

Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer

✍ Scribed by Hagemann, Andrea R.; Novetsky, Akiva P.; Zighelboim, Israel; Gao, Feng; Massad, L. Stewart; Thaker, Premal H.; Powell, Matthew A.; Mutch, David G.; Wright, Jason D.

Book ID: 121408570
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 264 KB
Volume: 131
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2013.09.032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Bevacizumab in Persist

Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

✍ Burger, R. A.; Sill, M. W.; Monk, B. J.; Greer, B. E.; Sorosky, J. I. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 112 KB

A phase II study of ramucirumab (IMC-112

A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma

✍ Penson, Richard T.; Moore, Kathleen M.; Fleming, Gini F.; Braly, Patricia; Schim 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 637 KB

Laparoscopic Cytoreduction for Advanced

Laparoscopic Cytoreduction for Advanced Primary and Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

✍ Nezhat, F.R.; Cho, J.E.; Liu, C.; Gretz, H.; Chuang, L. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Phase II trial of pemetrexed and carbopl

Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, fallopian tube, and primary peritoneal cancer

✍ Van Arsdale, A.; Einstein, M.H.; Brewer, M.A.; Timmins, P.F.; Wright, J.D.; Leis 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A phase II evaluation of mifepristone in

A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study

✍ Thomas F. Rocereto; William E. Brady; Mark S. Shahin; James S. Hoffman; Laurie S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase II evaluation of topotecan and nav

Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal cancer

✍ Thomas J. Herzog; Matthew A. Powell; Janet S. Rader; Randall K. Gibb; Lynne Lipp 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 424 KB